Neurovalens

Neurovalens company information, Employees & Contact Information

Explore related pages

Related company profiles:

Neurovalens is a global health-tech company focused on developing non-invasive neurostimulation products to solve some of the world’s most significant health challenges. The company’s Modius technology is FDA-cleared, non-invasive, and influences the deep parts of the brain with a small and safe electrical pulse. The noninvasive approach removes the need for surgical implantation and allows much earlier intervention in the treatment pathway. Neurovalens is currently working to release several versions of the technology to treat various disorders. Modius Sleep is the first product to be released in October of 2024. The Neurovalens headquarters is in Belfast, United Kingdom. Product Line: ● Modius Sleep (released October 2024) ● Modius Calm (release date TBD) ● Ongoing clinical trial research is currently taking place for additional products designed to treat PTSD, diabetes, and depression. About Modius Sleep Modius Sleep is a non-invasive, non-drug, physician-prescribed medical device that can help improve sleep for patients with chronic insomnia. Worn as a headset for 30 minutes each evening, it stimulates sleep neurons deep in the brain by using electrical vestibular nerve stimulation (VeNS), which is a non-invasive therapeutic method. The device sends a safe electrical pulse into the vestibular nerve, influencing the areas of the hypothalamus and brainstem that control circadian rhythm and sleep patterns. The neurostimulation is delivered through two self-adhesive electrode pads, which are placed on the skin behind each ear.

Company Details

Employees
30
Founded
-
Address
Belfast, Gb
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Belfast
Looking for a particular Neurovalens employee's phone or email?

Neurovalens Questions

News

Neurovalens Expands Access to Modius Sleep for Veterans Through U.S. Department of Veterans Affairs (VA) Program - Yahoo Finance

Neurovalens Expands Access to Modius Sleep for Veterans Through U.S. Department of Veterans Affairs (VA) Program Yahoo Finance

Belfast medtech Neurovalens bags £6m to scale global expansion - Silicon Republic

Belfast medtech Neurovalens bags £6m to scale global expansion Silicon Republic

Kate Willis Launching Modius Sleep - Woman's World

Kate Willis Launching Modius Sleep Woman's World

Neurovalens secures £6m investment in round led by Investment Fund for Northern Ireland - Med-Tech Insights

Neurovalens secures £6m investment in round led by Investment Fund for Northern Ireland Med-Tech Insights

Neurovalens Wins National Sleep Foundation's 2024 SleepTech® Award - Yahoo Finance

Neurovalens Wins National Sleep Foundation's 2024 SleepTech® Award Yahoo Finance

Wearable health tech firm Neurovalens raises £6m in new funding - UKTN

Wearable health tech firm Neurovalens raises £6m in new funding UKTN

FDA Clears Neurovalens’ Modius Sleep Device for Insomnia - NeurologyLive

FDA Clears Neurovalens’ Modius Sleep Device for Insomnia NeurologyLive

Neurovalens Appoints Kate Willis as Vice President of Commercialization - PRWeb

Neurovalens Appoints Kate Willis as Vice President of Commercialization PRWeb

Product Launch: Modius Sleep FDA-Cleared Non-Invasive Device that Treats Chronic Insomnia is Now Available for Purchase - PR Newswire

Product Launch: Modius Sleep FDA-Cleared Non-Invasive Device that Treats Chronic Insomnia is Now Available for Purchase PR Newswire

Neurovalens raises £6M for neurostimulation devices - BioWorld MedTech

Neurovalens raises £6M for neurostimulation devices BioWorld MedTech

Neurovalens launches Modius Sleep insomnia treatment through VA program - MassDevice

Neurovalens launches Modius Sleep insomnia treatment through VA program MassDevice

Neurotech startup Neurovalens gets FDA clearance for noninvasive anxiety treatment - TechCrunch

Neurotech startup Neurovalens gets FDA clearance for noninvasive anxiety treatment TechCrunch

Neurovalens Joins NSF at CES 2025 to Discuss Future of Sleep and Brain Health - Sleep Review

Neurovalens Joins NSF at CES 2025 to Discuss Future of Sleep and Brain Health Sleep Review

Neurovalens decks £2.1M funding and FDA clearance: A spotlight on 5 mental health wearables competing in Europe - Tech Funding News

Neurovalens decks £2.1M funding and FDA clearance: A spotlight on 5 mental health wearables competing in Europe Tech Funding News

Belfast-based Neurovalens closes £6m funding round - The Irish Times

Belfast-based Neurovalens closes £6m funding round The Irish Times

Neurovalens brings in $8.1M for neurostimulation tech - MassDevice

Neurovalens brings in $8.1M for neurostimulation tech MassDevice

Neurovalens secures US approval and closes £2.1m raise - BusinessCloud

Neurovalens secures US approval and closes £2.1m raise BusinessCloud

Neurovalens raises £2.1M and gains FDA approval for anxiety treatment wearable device - Tech.eu

Neurovalens raises £2.1M and gains FDA approval for anxiety treatment wearable device Tech.eu

Neurovalens: A novel, non-invasive solution to pervasive health issues - Silicon Republic

Neurovalens: A novel, non-invasive solution to pervasive health issues Silicon Republic

FDA clears non-invasive insomnia-treating device from Neurovalens - MassDevice

FDA clears non-invasive insomnia-treating device from Neurovalens MassDevice

Neurovalens secures £6m in new investment round led by IFNI - The Irish News

Neurovalens secures £6m in new investment round led by IFNI The Irish News

10 start-ups on a mission to extend lives - Swiss Life-Gruppe

10 start-ups on a mission to extend lives Swiss Life-Gruppe

Belfast’s Neurovalens raises £2.1m for wearable anxiety treatment - UKTN

Belfast’s Neurovalens raises £2.1m for wearable anxiety treatment UKTN

Neurovalens secures £5 million Series A Follow On investment led by IQ Capital - UK Tech Investment News

Neurovalens secures £5 million Series A Follow On investment led by IQ Capital UK Tech Investment News

Top Neurovalens Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant